Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis

• Үндсэн зохиолчид: Muthu K. Shanmugam (Зохиогч), Kwang Seok Ahn (Зохиогч), Annie Hsu (Зохиогч), Chern Chiuh Woo (Зохиогч), Yi Yuan (Зохиогч), Kwong Huat Benny Tan (Зохиогч), Arunachalam Chinnathambi (Зохиогч), Tahani Awad Alahmadi (Зохиогч), Sulaiman Ali Alharbi (Зохиогч), Angele Pei Fern Koh (Зохиогч), Frank Arfuso (Зохиогч), Ruby Yun-Ju Huang (Зохиогч), Lina H. K. Lim (Зохиогч), Gautam Sethi (Зохиогч), Alan Prem Kumar (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Frontiers Media S.A., 2018-12-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Overexpression of chemokine receptor type 4 (CXCR4) has been found to be associated with increased cell proliferation, metastasis and also act as an indicator of poor prognosis in patients with breast cancer. Therefore, new agents that can abrogate CXCR4 expression have potential against breast canc...